Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Compugen Ltd.
DescriptionGp96 antagonist
Molecular Target Heat shock 90 kDa protein beta 1 (Hsp90B1) (GP96) (GRP94)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat inflammatory bowel disease (IBD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today